BAP1-mutated mesothelioma

See also

 BAP1-mutated tumors

Open references

 BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, Yang H. J Transl Med. 2012 Aug 30;10:179. doi : 10.1186/1479-5876-10-179 PMID: 22935333 [Free]

References

 Molecular pathogenesis of malignant mesothelioma. Sekido Y. Carcinogenesis. 2013 May 14. PMID: 23677068

 Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ribeiro C, Campelos S, Moura CS, Machado JC, Justino A, Parente B. Ann Oncol. 2013 Apr 12. PMID: 23585512

 New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Ladanyi M, Zauderer MG, Krug LM, Ito T, McMillan R, Bott M, Giancotti F. Clin Cancer Res. 2012 Sep 1;18(17):4485-90. doi : 10.1158/1078-0432.CCR-11-2375 PMID: 22825583

 Germline BAP1 mutations predispose to malignant mesothelioma. Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M. Nat Genet. 2011 Aug 28;43(10):1022-5. doi : 10.1038/ng.912 PMID: 21874000